Back
Arrowhead Pharmaceuticals Stock Price Chart
Sponsored
ARWR
Sponsored
"This Changes Everything" - Trump Hands Millions Massive IRS Gift
Learn More Here
Sell
50
ARWR
Arrowhead Pharmaceuticals
Last Price:
21.51
Seasonality Move:
72.88%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ARWR is experiencing selling pressure, which indicates risk of future bearish movement.
Arrowhead Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 20.74 | Buy |
20-day SMA: | 20.41 | Buy |
50-day SMA: | 20.36 | Buy |
200-day SMA: | 25.21 | Sell |
8-day EMA: | 21.08 | Buy |
20-day EMA: | 20.49 | Buy |
50-day EMA: | 20.93 | Buy |
200-day EMA: | 24.46 | Sell |
Arrowhead Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.34 | Buy |
Relative Strength Index (14 RSI): | 65.16 | Buy |
Chaikin Money Flow: | -997600 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (18.74 - 21.12) | Buy |
Bollinger Bands (100): | (19.86 - 26.5) | Sell |
Arrowhead Pharmaceuticals Technical Analysis
Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Arrowhead Pharmaceuticals Stock
Is Arrowhead Pharmaceuticals Stock a Buy?
- Arrowhead Pharmaceuticals share price is 21.95 while ARWR 8-day simple moving average is 20.74, which is a Buy signal.
- The stock price of ARWR is 21.95 while Arrowhead Pharmaceuticals 20-day SMA is 20.41, which makes it a Buy.
- Arrowhead Pharmaceuticals 50-day simple moving average is 20.36 while ARWR share price is 21.95, making it a Buy technically.
- ARWR stock price is 21.95 and Arrowhead Pharmaceuticals 200-day simple moving average is 25.21, creating a Sell signal.
ARWR Technical Analysis vs Fundamental Analysis
Sell
50
Arrowhead Pharmaceuticals (ARWR)
is a Sell
Is Arrowhead Pharmaceuticals a Buy or a Sell?
-
Arrowhead Pharmaceuticals stock is rated a Sell
The current Arrowhead Pharmaceuticals [ARWR] share price is $21.95. The Score for ARWR is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
Arrowhead Pharmaceuticals Stock Info
Market Cap:
2.73B
Price in USD:
21.95
Share Volume:
1.24M
Arrowhead Pharmaceuticals 52-Week Range
52-Week High:
39.83
52-Week Low:
17.05
Sell
50
Arrowhead Pharmaceuticals (ARWR)
is a Sell
Arrowhead Pharmaceuticals Share Price Forecast
-
What is the Arrowhead Pharmaceuticals stock price today?
The Arrowhead Pharmaceuticals stock price is 21.95 USD today. -
Will ARWR stock go up or go down?
Arrowhead Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Arrowhead Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Arrowhead Pharmaceuticals is overvalued.
Is Arrowhead Pharmaceuticals Stock a Buy?
- Arrowhead Pharmaceuticals share price is 21.95 while ARWR 8-day exponential moving average is 21.08, which is a Buy signal.
- The stock price of ARWR is 21.95 while Arrowhead Pharmaceuticals 20-day EMA is 20.49, which makes it a Buy.
- Arrowhead Pharmaceuticals 50-day exponential moving average is 20.93 while ARWR share price is 21.95, making it a Buy technically.
- ARWR stock price is 21.95 and Arrowhead Pharmaceuticals 200-day simple moving average is 24.46, creating a Sell signal.
Fundamental Analysis of Arrowhead Pharmaceuticals
Is Arrowhead Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $3.09 per share, and an increase next year of $0.08 per share.
Technical Analysis of Arrowhead Pharmaceuticals
Should I short Arrowhead Pharmaceuticals stock?
- ARWR Moving Average Covergence Divergence (MACD) indicator is 0.34, suggesting Arrowhead Pharmaceuticals is a Buy
- Arrowhead Pharmaceuticals Relative Strength Index (RSI) is 65.16, which suggest Arrowhead Pharmaceuticals is overbought
- The Bollinger Bands (25) for Arrowhead Pharmaceuticals is (18.74 - 21.12), which suggest Arrowhead Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Arrowhead Pharmaceuticals is (19.86 - 26.5), which suggest Arrowhead Pharmaceuticals is a Sell
* Arrowhead Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.